Figure 1.
The SM‐PK/RO model diagram of anti‐NKG2A antibody therapies. mAB, monoclonal antibody; SM‐PK/RO, semimechanistic‐pharmacokinetic/receptor occupancy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.